Literature DB >> 19013792

Molecular modeling, synthesis, and activity studies of novel biaryl and fused-ring BACE1 inhibitors.

Srinivas Reddy Chirapu1, Boobalan Pachaiyappan, Hikmet F Nural, Xin Cheng, Hongbin Yuan, David C Lankin, Samer O Abdul-Hay, Gregory R J Thatcher, Yong Shen, Alan P Kozikowski, Pavel A Petukhov.   

Abstract

A series of transition state analogues of beta-secretases 1 and 2 (BACE1, 2) inhibitors containing fused-ring or biaryl moieties were designed computationally to probe the S2 pocket, synthesized, and tested for BACE1 and BACE2 inhibitory activity. It has been shown that unlike the biaryl analogs, the fused-ring moiety is successfully accommodated in the BACE1 binding site resulting in the ligands with excellent inhibitory activity. Ligand 5b reduced 65% of Abeta40 production in N2a cells stably transfected with Swedish human APP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013792      PMCID: PMC2643073          DOI: 10.1016/j.bmcl.2008.10.096

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  36 in total

Review 1.  The beta-amyloid precursor protein (APP) and Alzheimer's disease: does the tail wag the dog?

Authors:  Edward H Koo
Journal:  Traffic       Date:  2002-11       Impact factor: 6.215

2.  Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease.

Authors:  Li-Bang Yang; Kristina Lindholm; Riqiang Yan; Martin Citron; Weiming Xia; Xiao-Li Yang; Thomas Beach; Lucia Sue; Philip Wong; Donald Price; Rena Li; Yong Shen
Journal:  Nat Med       Date:  2003-01       Impact factor: 53.440

3.  Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.

Authors:  R Yan; M J Bienkowski; M E Shuck; H Miao; M C Tory; A M Pauley; J R Brashier; N C Stratman; W R Mathews; A E Buhl; D B Carter; A G Tomasselli; L A Parodi; R L Heinrikson; M E Gurney
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

4.  Structure-based design of potent and selective cell-permeable inhibitors of human beta-secretase (BACE-1).

Authors:  Shawn J Stachel; Craig A Coburn; Thomas G Steele; Kristen G Jones; Elizabeth F Loutzenhiser; Alison R Gregro; Hemaka A Rajapakse; Ming-Tain Lai; Ming-Chih Crouthamel; Min Xu; Katherine Tugusheva; Janet E Lineberger; Beth L Pietrak; Amy S Espeseth; Xiao-Ping Shi; Elizabeth Chen-Dodson; M Katharine Holloway; Sanjeev Munshi; Adam J Simon; Lawrence Kuo; Joseph P Vacca
Journal:  J Med Chem       Date:  2004-12-16       Impact factor: 7.446

Review 5.  An etiological role of amyloidogenic carboxyl-terminal fragments of the beta-amyloid precursor protein in Alzheimer's disease.

Authors:  Y H Suh
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

6.  Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice.

Authors:  Ilse Dewachter; Delphine Reversé; Nathalie Caluwaerts; Laurence Ris; Cuno Kuipéri; Chris Van den Haute; Kurt Spittaels; Lieve Umans; Lutgarde Serneels; Els Thiry; Dieder Moechars; Mark Mercken; Emile Godaux; Fred Van Leuven
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

7.  Memory function in very early Alzheimer's disease.

Authors:  R C Petersen; G E Smith; R J Ivnik; E Kokmen; E G Tangalos
Journal:  Neurology       Date:  1994-05       Impact factor: 9.910

Review 8.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

9.  Modeling the protonation states of the catalytic aspartates in beta-secretase.

Authors:  Ramkumar Rajamani; Charles H Reynolds
Journal:  J Med Chem       Date:  2004-10-07       Impact factor: 7.446

10.  Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes.

Authors:  Ayae Kinoshita; Hiroaki Fukumoto; Tejal Shah; Christa M Whelan; Michael C Irizarry; Bradley T Hyman
Journal:  J Cell Sci       Date:  2003-06-26       Impact factor: 5.285

View more
  5 in total

1.  Occludin deficiency with BACE1 elevation in cerebral amyloid angiopathy.

Authors:  Xin Cheng; Ping He; Hailan Yao; Qiang Dong; Rena Li; Yong Shen
Journal:  Neurology       Date:  2014-04-16       Impact factor: 9.910

2.  9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites.

Authors:  Jitesh R Shah; Philip D Mosier; Srinivas Peddi; Bryan L Roth; Richard B Westkaemper
Journal:  Bioorg Med Chem Lett       Date:  2009-12-23       Impact factor: 2.823

3.  Computational Methods Applied to Rational Drug Design.

Authors:  David Ramírez
Journal:  Open Med Chem J       Date:  2016-04-26

4.  Biaryl scaffold-focused virtual screening for anti-aggregatory and neuroprotective effects in Alzheimer's disease.

Authors:  Sidra Khalid; Muhammad Ammar Zahid; Hussain Ali; Yeong S Kim; Salman Khan
Journal:  BMC Neurosci       Date:  2018-11-13       Impact factor: 3.288

5.  Application of computational methods for the design of BACE-1 inhibitors: validation of in silico modelling.

Authors:  Marek Bajda; Jakub Jończyk; Barbara Malawska; Sławomir Filipek
Journal:  Int J Mol Sci       Date:  2014-03-24       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.